Hans Wijkström

2.7k total citations
69 papers, 2.0k citations indexed

About

Hans Wijkström is a scholar working on Surgery, Urology and Molecular Biology. According to data from OpenAlex, Hans Wijkström has authored 69 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Surgery, 19 papers in Urology and 18 papers in Molecular Biology. Recurrent topics in Hans Wijkström's work include Bladder and Urothelial Cancer Treatments (55 papers), Urinary and Genital Oncology Studies (31 papers) and Epigenetics and DNA Methylation (13 papers). Hans Wijkström is often cited by papers focused on Bladder and Urothelial Cancer Treatments (55 papers), Urinary and Genital Oncology Studies (31 papers) and Epigenetics and DNA Methylation (13 papers). Hans Wijkström collaborates with scholars based in Sweden, United States and United Kingdom. Hans Wijkström's co-authors include Gunnar Steineck, Per‐Uno Malmström, Bernhard Tribukait, Kari Hemminki, Lars Henningsohn, Ulf Norming, Christer Busch, Bo Johan Norlén, Kenneth Wester and Jari Louhelainen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Environmental Health Perspectives.

In The Last Decade

Hans Wijkström

66 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Wijkström Sweden 25 1.4k 501 376 337 294 69 2.0k
Thomas Paiss Germany 18 679 0.5× 327 0.7× 466 1.2× 410 1.2× 153 0.5× 45 1.4k
Gustavo Cardoso Guimarães Brazil 26 967 0.7× 388 0.8× 283 0.8× 445 1.3× 385 1.3× 103 1.8k
Suzanne Hasthorpe Australia 20 712 0.5× 593 1.2× 150 0.4× 218 0.6× 108 0.4× 50 1.4k
A Tizzani Italy 22 766 0.6× 375 0.7× 304 0.8× 731 2.2× 297 1.0× 97 1.8k
Ricardo Leão Portugal 19 771 0.6× 545 1.1× 116 0.3× 440 1.3× 145 0.5× 68 1.4k
Aivars Stengrēvics Latvia 22 338 0.2× 538 1.1× 48 0.1× 114 0.3× 283 1.0× 32 1.5k
M.A. Kuczyk Germany 22 696 0.5× 530 1.1× 202 0.5× 488 1.4× 247 0.8× 120 1.5k
Tomoyasu Tsushima Japan 25 673 0.5× 489 1.0× 218 0.6× 700 2.1× 304 1.0× 101 1.6k
Hugues Bittard France 21 700 0.5× 666 1.3× 148 0.4× 366 1.1× 253 0.9× 101 1.6k
Frank Christoph Germany 24 437 0.3× 944 1.9× 112 0.3× 352 1.0× 391 1.3× 71 1.7k

Countries citing papers authored by Hans Wijkström

Since Specialization
Citations

This map shows the geographic impact of Hans Wijkström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Wijkström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Wijkström more than expected).

Fields of papers citing papers by Hans Wijkström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Wijkström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Wijkström. The network helps show where Hans Wijkström may publish in the future.

Co-authorship network of co-authors of Hans Wijkström

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Wijkström. A scholar is included among the top collaborators of Hans Wijkström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Wijkström. Hans Wijkström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holmäng, Sten, Fredrik Liedberg, Börje Ljungberg, et al.. (2013). Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden. Scandinavian Journal of Urology. 47(6). 483–490. 17 indexed citations
2.
Kreicbergs, Ulrika, Erik Onelöv, Christer Ahlstrand, et al.. (2010). Defecation disturbances after cystectomy for urinary bladder cancer. British Journal of Urology. 108(2). 196–203. 14 indexed citations
3.
Steineck, Gunnar, Ulrika Kreicbergs, Erik Onelöv, et al.. (2009). Hygiene and urinary tract infections after cystectomy in 452 Swedish survivors of bladder cancer. British Journal of Urology. 105(8). 1107–1117. 11 indexed citations
5.
Henningsohn, Lars, Hans Wijkström, Kenneth Steven, et al.. (2003). Relative Importance of Sources of Symptom-Induced Distress in Urinary Bladder Cancer Survivors. European Urology. 43(6). 651–662. 41 indexed citations
6.
Henningsohn, Lars, Hans Wijkström, Gunnar Aus, et al.. (2003). Time after surgery, symptoms and well‐being in survivors of urinary bladder cancer. British Journal of Urology. 91(4). 325–330. 32 indexed citations
7.
Kaasinen, Eero, Hans Wijkström, Per‐Uno Malmström, et al.. (2003). Alternating Mitomycin C and BCG Instillations versus BCG Alone in Treatment of Carcinoma in Situ of the Urinary Bladder: A Nordic Study. European Urology. 43(6). 637–645. 65 indexed citations
8.
Henningsohn, Lars, Hans Wijkström, Paul W. Dickman, Karin Bergmark, & Gunnar Steineck. (2002). Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiotherapy and Oncology. 62(2). 215–225. 111 indexed citations
9.
Hardell, Lennart, Bert van Bavel, Gunilla Lindström, et al.. (2002). Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer.. Environmental Health Perspectives. 111(7). 930–934. 149 indexed citations
10.
Seddighzadeh, Maria, Gunnar Steineck, Per Larsson, et al.. (2002). Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms. International Journal of Cancer. 99(5). 721–726. 27 indexed citations
11.
Berggren, Petra, Gunnar Steineck, Jan Adolfsson, et al.. (2001). p53 mutations in urinary bladder cancer. British Journal of Cancer. 84(11). 1505–1511. 47 indexed citations
12.
Wada, Takashi, Jari Louhelainen, K. Hemminki, et al.. (2001). The prevalence of loss of heterozygosity in chromosome 3, including FHIT , in bladder cancer, using the fluorescent multiplex polymerase chain reaction. British Journal of Urology. 87(9). 876–881. 7 indexed citations
13.
Seddighzadeh, Maria, Gunnar Steineck, Olof Jansson, et al.. (2001). Low interleukin-1α messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma. British Journal of Cancer. 84(3). 329–334. 13 indexed citations
14.
Försti, Asta, Jari Louhelainen, Magnus Söderberg, Hans Wijkström, & Kari Hemminki. (2001). Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. European Journal of Cancer. 37(11). 1372–1380. 64 indexed citations
15.
Louhelainen, Jari, Hans Wijkström, & Kari Hemminki. (2000). Initiation-development modelling of allelic losses on chromosome 9 in multifocal bladder cancer. European Journal of Cancer. 36(11). 1441–1451. 15 indexed citations
16.
Hellström, Mats, et al.. (1993). Histopathological Changes inAndrogen-Deprived LocalizedProstatic Cancer. European Urology. 24(4). 461–465. 44 indexed citations
17.
Pedersen, K, Hans Wijkström, Reinhard Stege, et al.. (1993). Neoadjuvant GnRH-AgonistTreatment (Triptorelin andCyproterone Acetatefor Flare Protection) andTotal Prostatectomy. European Urology. 24(4). 456–460. 20 indexed citations
18.
Wijkström, Hans, Bo Nilsson, & Bernhard Tribukait. (1992). DNA Analysis in Predicting Survival of Irradiated Patients with Transitional Cell Carcinoma of Bladder. British Journal of Urology. 69(1). 49–55. 13 indexed citations
19.
Gustafson, H., et al.. (1991). Prophylactic Instillation Therapy of Superficial Bladder Cancer. Scandinavian Journal of Urology and Nephrology. 25(sup138). 187–191. 1 indexed citations
20.
Wijkström, Hans, F. Edsmyr, & Bo Nilsson. (1987). Treatment of Invasive Grade 3 Transitional Cell Bladder Cancer. European Urology. 13(5). 300–304. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026